Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100053, China.
School of Management, Beijing University of Chinese Medicine, Beijing 100029, China.
Can Respir J. 2020 Jan 8;2020:4936423. doi: 10.1155/2020/4936423. eCollection 2020.
There is a growing number of patients with sleep-disordered breathing (SDB) referred to sleep clinics. Therefore, a simple but useful screening tool is urgent. The NoSAS score, containing only five items, has been developed and validated in population-based studies.
To evaluate the performance of the NoSAS score for the screening of SDB patients from a sleep clinic in China, and to compare the predictive value of the NoSAS score with the STOP-Bang questionnaire.
We enrolled consecutive patients from a sleep clinic who had undergone apnea-hypopnea index (AHI) testing by type III portable monitor device at the hospital and completed the STOP-Bang questionnaire. The NoSAS score was assessed by reviewing medical records. Sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve (AUC) of both screening tools were calculated at different AHI cutoffs to compare the performance of SDB screening.
Of the 596 eligible patients (397 males and 199 female), 514 were diagnosed with SDB. When predicting overall (AHI ≥ 5), moderate-to-severe (AHI ≥ 15), and severe (AHI ≥ 30) SDB, the sensitivity and specificity of the NoSAS score were 71.2, 80.4, and 83.1% and 62.4, 49.3, and 40.7%, respectively. At all AHI cutoffs, the AUC ranged from 0.688 to 0.715 for the NoSAS score and from 0.663 to 0.693 for the STOP-Bang questionnaire. The NoSAS score had the largest AUC (0.715, 95% CI: 0.655-0.775) of diagnosing SDB at AHI cutoff of ≥5 events/h. NoSAS performed better in discriminating moderate-to-severe SDB than STOP-Bang with a marginally significantly higher AUC (0.697 vs. 0.663, =0.046).
The NoSAS score had good performance on the discrimination of SDB patients in sleep clinic and can be utilized as an effective screening tool in clinical practice.
越来越多患有睡眠呼吸障碍(SDB)的患者被转介到睡眠诊所。因此,迫切需要一种简单但有用的筛查工具。NoSAS 评分仅包含五个项目,已在基于人群的研究中开发和验证。
评估 NoSAS 评分在中国睡眠诊所筛查 SDB 患者的性能,并比较 NoSAS 评分与 STOP-Bang 问卷的预测价值。
我们连续招募了在医院使用 III 型便携式监测仪进行睡眠呼吸暂停低通气指数(AHI)测试并完成 STOP-Bang 问卷的睡眠诊所患者。通过回顾病历评估 NoSAS 评分。计算不同 AHI 截断值下两种筛查工具的灵敏度、特异性、阳性预测值、阴性预测值和受试者工作特征曲线下面积(AUC),以比较 SDB 筛查的性能。
在 596 名符合条件的患者(397 名男性和 199 名女性)中,514 名被诊断为 SDB。当预测整体(AHI≥5)、中重度(AHI≥15)和重度(AHI≥30)SDB 时,NoSAS 评分的灵敏度和特异性分别为 71.2%、80.4%和 83.1%和 62.4%、49.3%和 40.7%。在所有 AHI 截断值下,NoSAS 评分的 AUC 范围为 0.688 至 0.715,STOP-Bang 问卷的 AUC 范围为 0.663 至 0.693。NoSAS 评分在 AHI 截断值为≥5 事件/小时时对 SDB 的诊断具有最大 AUC(0.715,95%CI:0.655-0.775)。NoSAS 在区分中重度 SDB 方面的表现优于 STOP-Bang,AUC 略高(0.697 比 0.663,=0.046)。
NoSAS 评分在睡眠诊所中对 SDB 患者的鉴别具有良好的性能,可以作为临床实践中的有效筛查工具。